Proteomic Profile Distinguishes New Subpopulations of Breast Cancer Patients with Different Survival Outcomes
As a highly heterogeneous disease, breast cancer (BRCA) demonstrates a diverse molecular portrait. The well-established molecular classification (PAM50) relies on gene expression profiling. It insufficiently explains the observed clinical and histopathological diversity of BRCAs. This study aims to...
Main Authors: | Joanna Tobiasz, Joanna Polanska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/17/4230 |
Similar Items
-
Breast Cancer Subtypes in Northern Thailand and Barriers to satisfactory survival outcomes
by: Chagkrit Ditsatham, et al.
Published: (2022-11-01) -
Time-related survival prediction in molecular subtypes of breast cancer using time-to-event deep-learning-based models
by: Saba Zarean Shahraki, et al.
Published: (2023-06-01) -
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome
by: Burcu Çakar, et al.
Published: (2018-10-01) -
Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer
by: Almasri H, et al.
Published: (2022-10-01) -
Breast‐conserving therapy is associated with better survival than mastectomy in Early‐stage breast cancer: A propensity score analysis
by: Jiali Ji, et al.
Published: (2022-04-01)